Outlook Therapeutics (OTLK) Retained Earnings: 2015-2019
Historic Retained Earnings for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to -$254.5 million.
- Outlook Therapeutics' Retained Earnings fell 14.49% to -$279.8 million in Q2 2020 from the same period last year, while for Jun 2020 it was -$279.8 million, marking a year-over-year decrease of 14.49%. This contributed to the annual value of -$254.5 million for FY2019, which is 17.65% down from last year.
- Latest data reveals that Outlook Therapeutics reported Retained Earnings of -$254.5 million as of FY2019, which was down 17.65% from -$216.3 million recorded in FY2018.
- In the past 5 years, Outlook Therapeutics' Retained Earnings registered a high of -$94.1 million during FY2015, and its lowest value of -$254.5 million during FY2019.
- Its 3-year average for Retained Earnings is -$219.0 million, with a median of -$216.3 million in 2018.
- Data for Outlook Therapeutics' Retained Earnings shows a maximum YoY slumped of 56.67% (in 2016) over the last 5 years.
- Outlook Therapeutics' Retained Earnings (Yearly) stood at -$94.1 million in 2015, then tumbled by 56.67% to -$147.4 million in 2016, then decreased by 26.36% to -$186.2 million in 2017, then fell by 16.16% to -$216.3 million in 2018, then decreased by 17.65% to -$254.5 million in 2019.